News
Filters
Showing 1 - 10 out of 20 results
News
CoxHealth and St. Louis Children’s Hospital to Expand Pediatric Care Across Southwest Missouri
Springfield and St. Louis, Missouri, (June 12, 2025) – Increased access to highly specialized pediatric care just moved one step closer to becoming a reality today as CoxHealth and St. Louis Children’s Hospital – one of the nation’s premier pediatric hospitals – announced they have finalized an agreement to expand pediatric care in southwest Missouri. The agreement follows a letter of intent signed in May 2024 by both organizations.
News
Strokes During Commute Turned MoBap Provider Into Grateful Patient
News
St. Louis Children's Ranked No. 1 in Pediatrics in St. Louis by U.S. News and World Report
Article
Is There a Difference Between Sports Physicals and Well Child Exams?
Article
Here’s How a Pediatrician Chooses the Best Sunscreen for Kids
Article
Women’s health: How you can live a healthier life at any age, starting now
It’s no secret that when women are healthy, families and communities thrive. But from menstruation to menopause, women face many distinct — and sometimes complex — health events that require care, understanding and partnership from a health care provider.
Article
Who Should Get Screened for Lung Cancer?
Article
Top 5 Halloween Hazards and How to Avoid Them
Halloween is the most fun day of the year for many. It is a time for fantasy, parties and excitement, but it is also important to be aware of potential dangers.
News
For the first time in St. Louis, a robotic arm guides physicians in performing a lung biopsy — and might be key in diagnosing lung cancer earlier
In a surgical suite at Barnes-Jewish Hospital, a robotic arm snakes an ultra-thin, ultra-flexible tube through a patient’s airway. Once the tube reaches the lungs, the surgeon operating the device remotely uses a tiny camera to search the area for an abnormal growth, or nodule, that might be cancerous. Once located, a needle pierces the nodule for biopsy.
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.